Section Arrow
APRE.NASDAQ
- Aprea Therapeutics
Quotes are at least 15-min delayed:2024/05/16 11:04 EDT
Last
 5.9
+0.1 (+1.72%)
Day High 
5.9 
Prev. Close
5.8 
1-M High
5.98 
Volume 
3.81K 
Bid
5.8
Ask
5.9
Day Low
5.8 
Open
5.8 
1-M Low
4.9001 
Market Cap 
31.50M 
Currency USD 
P/E 0.42 
%Yield
10-SMA 5.47 
20-SMA 5.37 
50-SMA 5.94 
52-W High 8.8465 
52-W Low 2.78 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.95/-1.64
Enterprise Value
31.50M
Balance Sheet
Book Value Per Share
3.12
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
SCPXScorpius Holdings0.097+0.0193+24.84%-- 
JAGXJaguar Health0.2695+0.0144+5.64%-- 
DNAGinkgo Bioworks Holdings0.8267-0.0124-1.48%-- 
NVAXNovavax12.91+0.01+0.08%-- 
NBYNovaBay Pharmaceuticals0.1-0.0045-4.31%-- 
Quotes are at least 15-min delayed:2024/05/16 11:04 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53reactivator that is in late-stage clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML).
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.